Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Annals of allergy

• Publication date

  1986-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 2945499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine

  2005cited by this paper
• The inhibitory effect of antiallergy drugs on allergen and histamine induced wheal and flare response.

  1973cited by this paper
• Degree and duration of skin test suppression and side effects with antihistamines. A double blind controlled study with five antihistamines.

  1973cited by this paper
• The evaluation of histamine antagonists in man

  1971cited by this paper

• High‐risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database

  2024cites this paper
• Development and Validation of a HPLC Method for Estimation of Loratadine and its Application to a Pharmacokinetic Study

  2019cites this paper
• Antihistamines and allergy.

  2018cites this paper
• The experiment of using loratadinum in pregnant women with pruritic dermatoses

  2016cites this paper
• Second-Generation Antihistamines

  2012cites this paper
• Inhibition of the histamine‐induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?

  2007cites this paper
• [Does new antihistamines characterize tachyphylaxis phenomenon?].

  2007cites this paper
• Czy nowe leki przeciwhistaminowe cechuje zjawisko tachyfilaksji

  2007cites this paper
• Predicting and Establishing the Clinical Efficacy of a Histamine H1-Receptor Antagonist

  2005cites this paper
• Les anti-H1 en pratique dermatologique

  2005cites this paper
• Effect of loratadine on mouse models of atopic dermatitis associated pruritus.

  2005cites this paper
• [Anti-H1 in dermatological practice].

  2005cites this paper
• Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl

  2004cites this paper
• Tolerance to Daytime Sedative Effects of H1 Antihistamines

  2002cites this paper
• Comparison of the effects of levocetirizine and loratadine on histamine‐induced wheal, flare, and itch in human skin

  2001cites this paper
• SOAP: solutions to often asked problems. Choice of antihistamines for urticaria.

  2000cites this paper
• Clinical Pharmacology of New Histamine H1 Receptor Antagonists

  1999cites this paper
• Effects of acrivastine, loratadine and cetirizine on histamine‐induced wheal and flare responses

  1999cites this paper
• A double‐blind, single‐dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine‐induced wheal and flare response for 24 h in healthy male subjects

  1999cites this paper
• Comparative Tolerability of Second Generation Antihistamines

  1999cites this paper
• Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.

  1999cites this paper
• Measurement of drug action in man: Psychometric aspects of antihistamines.

  1999cites this paper
• Effect of continuous allergen challenge on clinical symptoms and mediator release in dust‐mite‐allergic patients

  1998cites this paper
• Changes in skin‐test reactivity do not correlate with clinical efficacy of H1‐blockers in seasonal allergic rhinitis

  1998cites this paper
• Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines.

  1997cites this paper
• Loratadine in the treatment of urticaria.

  1997cites this paper
• Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis

  1997cites this paper
• Lack of subsensitivitvy to mizolastine over 8‐week treatment

  1996cites this paper
• SAFETY AND EFFICACY OF LORATADINE IN URTICARIA

  1996cites this paper
• Effect of loratadine on immediate and delayed type hypersensitivity reactions.

  1995cites this paper
• Pharmacology of the histaminergic system

  1995cites this paper
• Loratadine and cetirizine in the treatment of chronic urticaria

  1994cites this paper
• Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.

  1994cites this paper
• Loratadine

  1994cites this paper
• Evaluation of the efficacy of H1 blockers by noninvasive measurement techniques.

  1994cites this paper
• H1-Receptor Antagonists in the Management of Allergic Rhinitis

  1994cites this paper
• Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.

  1993cites this paper
• H1-receptor antagonists: does a dose-response relationship exist?

  1993cites this paper
• Agonist-antagonist interactions in the skin: comparison of effects of loratadine and cetirizine on skin vascular responses to prick tests with histamine and substance P.

  1992cites this paper
• Developments in antihistamines (H1).

  1992cites this paper
• Are terfenadine and astemizole non‐sedative antihistamine compounds? A meta‐analysis

  1992cites this paper
• Comparative inhibition profiles of three non‐sedating antihistamines assessed by an extended Lewis model *

  1992cites this paper
• Second-generation H1-receptor antagonists.

  1991cites this paper
• Pharmacokinetic Optimisation of Histamine H1-Receptor Antagonist Therapy

  1991cites this paper
• Guidelines for the standardization of bronchial provocation tests with allergens

  1991cites this paper
• A Comparison of Central and Peripheral Effects of Cetirizine and Loratadine

  1991cites this paper
• Lack of subsensitivity to loratadine during long-term dosing during 12 weeks.

  1990cites this paper
• Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.

  1990cites this paper
• Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine.

  1990cites this paper
• A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis

  1990cites this paper
• Pharmacological Modulation by Cetirizine and Loratadine of Antigen and Histamine-Induced Skin Weals and Flares, and Late Accumulation of Eosinophils

  1990cites this paper
• Treatment of hay fever with loratadine ‐ a new non‐sedating antihistamine

  1990cites this paper
• New H1‐receptor antagonists: clinical pharmacology

  1990cites this paper
• Loratadine: A Nonsedating Antihistamine with Once-Daily Dosing

  1989cites this paper
• Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat.

  1989cites this paper
• Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis

  1989cites this paper
• Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis.

  1989cites this paper
• SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.

  1989cites this paper
• Antihistamine agents: new options or just more drugs?

  1989cites this paper
• Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.

  1989cites this paper
• Duration of inhibition of immediate skin test reactivity by hydroxyzine hydrochloride in dogs.

  1989cites this paper
• Optimum Pharmacological Management of Chronic Rhinitis

  1989cites this paper
• Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.

  1989cites this paper
• H1-receptor antagonists: clinical pharmacology and therapeutics.

  1989cites this paper
• Loratadine, a non-sedating H1-receptor antagonist (antihistamine)

  1989cites this paper
• Antihistamines.

  1989cites this paper
• Tolerance to antihistamines: is it a problem?

  1989cites this paper
• New H1-Receptor Antagonists: A Review

  1988cites this paper
• Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.

  1988cites this paper
• Lack of subsensitivity to terfenadine during long-term terfenadine treatment.

  1988cites this paper
• Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria.

  1988cites this paper
• Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis.

  1988cites this paper
• Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.

  1988cites this paper
• H1 receptor antagonist treatment of chronic rhinitis.

  1988cites this paper
• Effects of loratadine (SCH 29851) in suppression of histamine-induced skin wheals.

  1988cites this paper
• A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.

  1988cites this paper
• A Comparison of Loratadine, a New Nonsedating Antihistamine, with Clemastine and Placebo in Patients with Fall Seasonal Allergic Rhinitis

  1987cites this paper
• Loratadine (SCH29851) 40 mg Once Daily versus Terfenadine 60 mg Twice Daily in the Treatment of Seasonal Allergic Rhinitis

  1987cites this paper
• Loratadine: A Potent, Nonsedating, and Long-Acting H1 Antagonist

  1987cites this paper
• The comparative pharmacokinetics of H1-receptor antagonists.

  1987cites this paper